Table 1.
Pathway | NES | p-value | FDR (q-value) |
---|---|---|---|
Ox Phos | −1.79 | 0 | 0.006 |
|
|||
FA Met | −1.95 | 0.002 | 0.001 |
|
|||
Glycolysis/Gluconeogenesis | −1.64 | 0.004 | 0.02 |
|
|||
Citrate Cycle | −1.75 | 0.002 | 0.009 |
|
|||
PPP | −1.66 | 0.012 | 0.017 |
|
|||
TH17 signature | −1.37 | 0.094488 | 0.094 |
|
|||
TFs associted to RORγ | −0.73 | 0.883019 | 0.883 |
|
Gene set enrichment analysis (GSEA) of the running enrichment score (ES) based on fold change of in vitro TH17 (CD45.1+ CD4+IL-17GFP+) versus in vivo TH17 (CD45.2+ CD4+IL-17GFP+). NES (normalized enrichment score); FDR (false discovery rate).